NCT02459938View on ClinicalTrials.gov

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2015

Conditions
Hypoglycemia
Interventions
DRUG

Glucagon (ZP-Glucagon)

chemically synthesized glucagon as delivered via transdermal microneedle patch system for 30 minutes

DRUG

Glucagon (GlucaGen)

recombinant glucagon administered via subcutaneous injection

Trial Locations (1)

3005

Nucleus Network, Melbourne

All Listed Sponsors
lead

Zosano Pharma Corporation

INDUSTRY

NCT02459938 - Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia | Biotech Hunter | Biotech Hunter